Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.

Daiichi Pharmaceuticals
ClinicalTrials.gov · Datasets · License: Public Domain
Open Source ↗
acquired-immunodeficiency-syndromeantineoplastic-agentshiv-infectionsneoplasms
sarcoma, kaposi, hiv infections, neoplasms, acquired immunodeficiency syndrome, antineoplastic agents, tecogalan, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 903825
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.